Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
success tags : Covid-19 save search
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
VERV | $6.66 -1.19% -1.2% 1.2M
|
Professional, Scientific, and T...
|
| O: 0.37%
H: 0.64%
C: -10.76%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.23%
MRNA S | $102.0 -1.39% -1.4% 1.4M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
CVAC | News | $2.44 -5.06% -5.33% 120
|
Health Technology
|
| O: 0.91%
H: 1.08%
C: -1.44%
BNTX | $86.17 -0.27% -0.24% 520K
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.81%
ARCT 4 | $26.32 -4.78% -5.06% 610K
|
Health Technology
|
| O: -0.36%
H: 0.79%
C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market
Sorrento Successfully Completes Phase 1 Study and Is Proceeding to Implement Global Registrational Trials with STI-1558, an Oral Mpro Inhibitor as a Standalone Oral Treatment and Prevention of COVID-19 without the Need for a Ritonavir Booster
Published: 2022-10-17 (Crawled : 13:00) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 4.48%
H: 11.43%
C: 9.29%
sti-1558 covid-19 treatment trials global study
Sorrento Completes Successfully the SAD Study and Initiates the MAD Phase 1 Study with STI-1558, An Oral M(pro) Inhibitor as a Standalone Treatment and Prevention of COVID-19 without the Ritonavir as Booster
Published: 2022-08-03 (Crawled : 13:20) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 0.77%
H: 8.32%
C: 2.3%
sti-1558 covid-19 treatment study
Press Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Published: 2022-06-24 (Crawled : 06:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 8.01%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
covid-19 report vaccine
Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle Patch
Published: 2022-05-17 (Crawled : 18:00) - biospace.com/
ZSAN | $0.5576 7.23% -5.85%
|
Health Technology
|
| O: 2.72%
H: 7.32%
C: 6.88%
covid-19 vaccine
Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
MRNA S | $102.0 -1.39% -1.4% 1.4M
|
Health Technology
|
| O: -1.1%
H: 0.59%
C: -3.21%
covid-19 children vaccine phase 2
Therapeutic Solutions International Successfully Treats “No Option” Patients with its JadiCell™ Stem Cell Therapy While Advancing Preparations for Phase III COVID-19 Clinical Trial
Published: 2021-12-30 (Crawled : 16:00) - biospace.com/
TSOI | $0.0007 0.0% 0
|
Manufacturing
|
| O: 4.48%
H: 5.71%
C: -10.29%
covid-19 trial covid cel stem cell therapy
Empower Clinics Successfully Completes Health Canada Review To Sell Covid-19 At-Home Saliva Collection Kit
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
EPWCF | $0.0001 33700.0% 250
|
Health Services
|
| O: 6.05%
H: 21.42%
C: 14.49%
saliva covid covid-19
Mandates, boosters and pediatric vaccines: How to successfully manage the next phase of COVID-19 vaccination
Published: 2021-10-18 (Crawled : 17:00) - phreesia.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.8%
H: 1.87%
C: -0.28%
covid vaccine covid-19
Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals
Published: 2021-09-20 (Crawled : 15:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -3.65%
H: 0.0%
C: 0.0%
covid animals test vaccine defense covid-19
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
Published: 2021-07-15 (Crawled : 22:00) - globenewswire.com
IBIO | $1.77 -6.35% 1.7% 180K
|
Health Technology
|
| O: 3.05%
H: 3.7%
C: -2.22%
covid leo vaccine preclinical covid-19 pre-clinical
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients
Published: 2021-04-12 (Crawled : 12:00) - globenewswire.com
OPGN A | $0.6161 2.7% -3.25% 170K
|
Commercial Services
|
| O: 0.09%
H: 0.0%
C: -4.2%
covid results injection covid-19 infections
Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 Created
Published: 2020-05-22 (Crawled : 22:16) - globenewswire.com
GENE | News 0 d | $2.44 -22.79% -33.9% 86K
|
Health Technology
| Email alert
Add to watchlist
risk covid prototype covid-19
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
UMAC | $1.55 0.65% 12.9% 0
|
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.